Furthermore, we mined sequencing data for 126 pancreatic adenocarcinoma patient-derived xenograft (PDX) models and identified an additional KRAS wild-type tumour with a PDZRN3-RAF1 fusion, which conserves the RAF1 kinase domain (Supplementary Fig. 4f). This evidence concerns the gene KRAS and pancreatic adenocarcinoma.